ABSTRACT
The anticonvulsants gabapentin and pregabalin are of interest to dermatologists. The drugs have found uses in conditions that are frequently of interest to dermatologists and often primarily present to a dermatologist. These drugs are likely to find greater use in dermatology practice in future. This review is intended to familiarize dermatologists with these drugs.
ABSTRACT
Background: Beetle dermatitis is a common condition seen in regions with warm and tropical climate. The condition causes significant morbidity and can be misdiagnosed. Aim: The study was conducted to know the clinical profile of beetle dermatitis and to increase awareness among nondermatologist physicians about this condition. Methods: All clinically diagnosed cases of beetle dermatitis were included in the study. Detailed history was taken and a thorough clinical examination was conducted in all the cases. Clinical photographs were taken in all the cases. Results: A total of 70 cases comprising of 46 males and 24 females were studied. The age of the patients ranged from 5 to 60 years. Majority of the cases presented during the post monsoon months (September-November), indicating a distinct seasonal trend. Morphology of lesions was mainly linear, but kissing and bizarre lesions were also observed. Head, neck and upper extremities were the most commonly involved sites. Fever and malaise was observed in a few cases. Conclusion: Beetle dermatitis should be included in differential diagnosis while examining erythematous vesicular lesions of sudden onset, especially on exposed parts during rainy and post rainy season. Awareness of this condition and its clinical features among the physicians will prevent misdiagnosis. Preventive measures can be undertaken based on the behavioral pattern of this beetle.
ABSTRACT
Background: Abuse of topical corticosteroids (TC), especially over the face, is prevalent worldwide, including in India. Data about the magnitude of this problem in our country is lacking. Aims: The aims of this study were to ascertain the demographics, magnitude and clinical features of TC misuse on the face in the dermatology outpatient department (OPD) attendees in order to raise awareness about this problem and to analyze its causes. Methods: This was a prospective multicenter questionnaire-based clinical study conducted at 12 dermatology centers nationwide. Patients with relevant facial dermatoses reporting to the investigator were asked about their current use of over-the-counter topical formulations and a structured questionnaire applied in case the same was confirmed to be TC. Results: A total of 2926 patients with facial dermatoses were screened, of which 433 (14.8%) were using TC. TC was used as a fairness/general purpose cream or aftershave in 126 (29%) and in 104 (24%) for acne. Steroid combinations were used by 258 (59.6%). Potent and super-potent TC were significantly (P = 0.05) more frequently used by the rural/suburban population. The younger age groups used more potent formulations. A non-physician recommendation for TC use was obtainable in 257 (59.3%) patients. Of these, 232 (90.3%) were for potent/super-potent steroids. Among 176 physician prescriptions, 78 (44.3%) were from non-dermatologists. All non-physician prescriptions and 146 (83%) physician prescriptions for TC were inappropriately refilled. Adverse effects were seen in 392 (90.5%) TC users. Acne/exacerbation of acne was the most common adverse effect. Conclusions: TC misuse in patients with facial dermatoses is quite common, and most of this use is unwarranted. Use as a fairness cream is the most common indication in this cohort. Limitations: This was an OPD-based study and, therefore, it may or may not accurately reflect the community data.